Flublok Quadrivalent regulatory update

FDA approved an sBLA from Protein Sciences for Flublok Quadrivalent to prevent 2 influenza A subtype viruses and 2 type B viruses. The company plans to launch Flublok Quadrivalent in 2017. The quadriv...